15,677 results on '"NEUROFIBROMATOSIS 1"'
Search Results
2. Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
3. A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
4. Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
5. Natural History Study of Patients With Neurofibromatosis Type I
6. Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
7. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
8. Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
9. Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
10. AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
11. US Selumetinib Registry
12. Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to (SPRINKLE)
13. Real-World Treatment Study of Koselugo (Selumetinib)
14. PASS of Paediatric Patients Initiating Selumetinib
15. Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET)
16. NF-1, Nutraceutical Intervention
17. MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
18. Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)
19. Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
20. Natural History Study of Patients With Neurofibromatosis Type 2
21. Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
22. Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
23. Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110)
24. Pediatric Long-Term Follow-up and Rollover Study
25. Neurofibromatosis Type 1 Tumor Early Detection Study (NF1-TED)
26. Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
27. MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (ReNeu)
28. Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
29. Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
30. A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
31. A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 (INSPIRE-NF1)
32. Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
33. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 (NF114)
34. A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
35. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.
36. Relationship Stressors in Parents of Children With Cancer or Neurofibromatosis Type 1 (NF1)
37. Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
38. Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas (NF113)
39. Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
40. Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
41. Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601)
42. Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
43. Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
44. Validating Pain Scales in Children and Young Adults
45. Interventions for Reading Disabilities in NF1
46. Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
47. Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials
48. Familial Investigations of Childhood Cancer Predisposition (SJFAMILY)
49. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.
50. Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (Mirda)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.